Perimeter Solutions Completes Acquisition of Medical Manufacturing Technologies for $685 Million

Reuters
Jan 23
Perimeter Solutions Completes Acquisition of Medical Manufacturing Technologies for $685 Million

Perimeter Solutions has completed its acquisition of Medical Manufacturing Technologies LLC $(MMT)$ from Arcline Investment Management for approximately $685 million in cash, including certain tax benefits. The transaction was financed with cash on hand and proceeds from a senior secured notes offering that closed earlier in January. MMT is known for its highly engineered machinery and aftermarket products used in the manufacturing of minimally invasive medical devices, with nearly all of its revenue coming from proprietary products and about half from aftermarket sales. The signing of the definitive agreement for this deal was previously announced in December.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perimeter Solutions SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9630905-en) on January 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10